648 related articles for article (PubMed ID: 17395050)
1. Carvedilol improves left atrial and left ventricular function and reserve in dilated cardiomyopathy after 1 year of treatment.
Paraskevaidis I; Farmakis D; Parissis JT; Dodouras T; Filippatos G; Tsiapras D; Kremastinos DT
J Card Fail; 2007 Mar; 13(2):108-13. PubMed ID: 17395050
[TBL] [Abstract][Full Text] [Related]
2. An echocardiographic analysis of the long-term effects of carvedilol on left ventricular remodeling, systolic performance, and ventricular filling patterns in dilated cardiomyopathy.
Rahko PS
Echocardiography; 2005 Aug; 22(7):547-54. PubMed ID: 16060890
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group.
Di Lenarda A; Sabbadini G; Salvatore L; Sinagra G; Mestroni L; Pinamonti B; Gregori D; Ciani F; Muzzi A; Klugmann S; Camerini F
J Am Coll Cardiol; 1999 Jun; 33(7):1926-34. PubMed ID: 10362195
[TBL] [Abstract][Full Text] [Related]
4. Dobutamine stress 99mTc-tetrofosmin quantitative gated SPECT predicts improvement of cardiac function after carvedilol treatment in patients with dilated cardiomyopathy.
Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Tange S; Suzuki T; Kurabayashi M
J Nucl Med; 2004 Nov; 45(11):1878-84. PubMed ID: 15534058
[TBL] [Abstract][Full Text] [Related]
5. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
Tatli E; Kurum T
Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561
[TBL] [Abstract][Full Text] [Related]
6. Myocardial contractile reserve under low doses of dobutamine and improvement of left ventricular ejection fraction with treatment by carvedilol.
Jourdain P; Funck F; Fulla Y; Hagege A; Bellorini M; Guillard N; Loiret J; Thebault B; Desnos M
Eur J Heart Fail; 2002 Jun; 4(3):269-76. PubMed ID: 12034151
[TBL] [Abstract][Full Text] [Related]
7. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
Quaife RA; Gilbert EM; Christian PE; Datz FL; Mealey PC; Volkman K; Olsen SL; Bristow MR
Am J Cardiol; 1996 Oct; 78(7):779-84. PubMed ID: 8857482
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of beta-blockers on left ventricular dyssynchrony and reverse remodeling in idiopathic dilated cardiomyopathy: A randomized trial of carvedilol and metoprolol.
Kaya MG; Sarli B; Akpek M; Kaya EG; Yarlioglues M; Topsakal R; Lam YY
Cardiol J; 2014; 21(4):434-41. PubMed ID: 24142686
[TBL] [Abstract][Full Text] [Related]
9. Effects of carvedilol on left ventricular function and oxidative stress in infants and children with idiopathic dilated cardiomyopathy: a 12-month, two-center, open-label study.
Bajcetic M; Kokic Nikolic A; Djukic M; Kosutic J; Mitrovic J; Mijalkovic D; Jovanovic I; Simeunovic S; Spasic MB; Samardzic R
Clin Ther; 2008 Apr; 30(4):702-14. PubMed ID: 18498919
[TBL] [Abstract][Full Text] [Related]
10. Treatment of dilated cardiomyopathy with carvedilol in children.
Erdoğan I; Ozer S; Karagöz T; Celiker A; Ozkutlu S; Alehan D
Turk J Pediatr; 2009; 51(4):354-60. PubMed ID: 19950843
[TBL] [Abstract][Full Text] [Related]
11. Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.
Chen L; Meyers D; Javorsky G; Burstow D; Lolekha P; Lucas M; Semmler AB; Savarimuthu SM; Fong KM; Yang IA; Atherton J; Galbraith AJ; Parsonage WA; Molenaar P
Pharmacogenet Genomics; 2007 Nov; 17(11):941-9. PubMed ID: 18075464
[TBL] [Abstract][Full Text] [Related]
12. Relation of early improvement in coronary flow reserve to late recovery of left ventricular function after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
Sugioka K; Hozumi T; Takemoto Y; Ehara S; Ogawa K; Iwata S; Oe H; Matsumura Y; Otsuka R; Yoshiyama M; Yoshikawa J
Am Heart J; 2007 Jun; 153(6):1080.e1-6. PubMed ID: 17540213
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of nebivolol versus carvedilol on left ventricular function and exercise capacity in patients with nonischemic dilated cardiomyopathy. A 12-month study.
Patrianakos AP; Parthenakis FI; Mavrakis HE; Diakakis GF; Chlouverakis GI; Vardas PE
Am Heart J; 2005 Nov; 150(5):985. PubMed ID: 16290981
[TBL] [Abstract][Full Text] [Related]
14. Improvement in left ventricular function in response to carvedilol is accompanied by attenuation of neurohumoral activation in patients with dilated cardiomyopathy.
Fujimura M; Yasumura Y; Ishida Y; Nakatani S; Komamura K; Yamagishi M; Miyatake K
J Card Fail; 2000 Mar; 6(1):3-10. PubMed ID: 10746813
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy.
Rhodes J; Margossian R; Darras BT; Colan SD; Jenkins KJ; Geva T; Powell AJ
Pediatr Cardiol; 2008 Mar; 29(2):343-51. PubMed ID: 17885779
[TBL] [Abstract][Full Text] [Related]
16. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol.
Capomolla S; Febo O; Gnemmi M; Riccardi G; Opasich C; Caporotondi A; Mortara A; Pinna GD; Cobelli F
Am Heart J; 2000 Apr; 139(4):596-608. PubMed ID: 10740140
[TBL] [Abstract][Full Text] [Related]
17. Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance.
Metra M; Nodari S; Parrinello G; Giubbini R; Manca C; Dei Cas L
Am Heart J; 2003 Feb; 145(2):292-9. PubMed ID: 12595847
[TBL] [Abstract][Full Text] [Related]
18. Myocardial beta-adrenergic receptor density assessed by 11C-CGP12177 PET predicts improvement of cardiac function after carvedilol treatment in patients with idiopathic dilated cardiomyopathy.
Naya M; Tsukamoto T; Morita K; Katoh C; Nishijima K; Komatsu H; Yamada S; Kuge Y; Tamaki N; Tsutsui H
J Nucl Med; 2009 Feb; 50(2):220-5. PubMed ID: 19164238
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of carvedilol to abolish myocardial postsystolic shortening in patients with idiopathic dilated cardiomyopathy.
Ito T; Kawanishi Y; Futai R; Terasaki F; Kitaura Y
Am J Cardiol; 2009 Dec; 104(11):1568-73. PubMed ID: 19932794
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of nebivolol and carvedilol on left ventricular diastolic function in older heart failure patients with preserved ejection fraction: study protocol for a randomized controlled trial.
Park K; Park TH
Trials; 2016 Nov; 17(1):530. PubMed ID: 27809882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]